Astera Labs (NASDAQ:ALAB) Reaches New 1-Year High – Here’s Why

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $398.37 and last traded at $405.2750, with a volume of 825886 shares. The stock had previously closed at $374.68.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on ALAB. UBS Group began coverage on Astera Labs in a research note on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price objective for the company. Citigroup cut Astera Labs from a “buy” rating to a “market perform” rating in a research note on Tuesday, May 26th. Needham & Company LLC boosted their price target on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Loop Capital began coverage on shares of Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 price target for the company. Finally, Rothschild & Co Redburn started coverage on shares of Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective on the stock. Twelve research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $233.75.

Check Out Our Latest Report on Astera Labs

Astera Labs Stock Performance

The stock has a market cap of $71.49 billion, a P/E ratio of 281.80, a price-to-earnings-growth ratio of 5.52 and a beta of 3.95. The stock’s 50-day moving average is $264.43 and its 200-day moving average is $187.34.

Astera Labs (NASDAQ:ALABGet Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The company had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. Astera Labs’s revenue was up 93.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities analysts forecast that Astera Labs, Inc. will post 1.84 EPS for the current year.

Insider Activity

In other Astera Labs news, General Counsel Philip Mazzara sold 796 shares of the stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $291.03, for a total transaction of $231,659.88. Following the completion of the transaction, the general counsel directly owned 103,343 shares of the company’s stock, valued at approximately $30,075,913.29. This trade represents a 0.76% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Jack R. Lazar sold 10,000 shares of Astera Labs stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the transaction, the director owned 75,688 shares in the company, valued at approximately $26,882,106.96. This trade represents a 11.67% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 2,161,256 shares of company stock valued at $459,844,296 over the last 90 days. Corporate insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Assetmark Inc. raised its position in Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after acquiring an additional 101 shares in the last quarter. Reflection Asset Management bought a new position in shares of Astera Labs during the 4th quarter valued at about $25,000. Smartleaf Asset Management LLC grew its stake in shares of Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares during the last quarter. Hilltop National Bank grew its stake in shares of Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after purchasing an additional 100 shares during the last quarter. Finally, Aventura Private Wealth LLC bought a new stake in shares of Astera Labs in the 4th quarter worth approximately $33,000. Institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Articles

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.